Open access · CC-BY
via OpenAlex
Lipofuscin accumulation in aging and neurodegeneration: a potential “timebomb” overlooked in Alzheimer’s disease
Godfried Dougnon, Hideaki Matsui
Translational Neurodegeneration · 2025 · ▲ 20 citations
Abstract
Lipofuscin, a marker of aging, is the accumulation of autofluorescent granules within microglia and postmitotic cells such as neurons. Lipofuscin has traditionally been regarded as an inert byproduct of cellular degradation. However, recent findings suggest that lipofuscin may play a role in modulating age-related neurodegenerative processes, and several questions remain unanswered. For instance, why do lipofuscin granules accumulate preferentially in aged neurons and microglia? What happens to these pigments upon neuronal demise? Particularly in neurodegenerative diseases like Alzheimer's disease (AD), why does amyloid β (Aβ) deposition usually begin in late adulthood or during aging? Why do lipofuscin and amyloid plaques appear preferentially in grey matter and rarely in white matter? In this review, we argue that lipofuscin should be revisited not as a simple biomarker of aging, but as a potential modulator of neurodegenerative diseases. We synthesize emerging evidence linking lipofuscin to lysosomal dysfunction, oxidative stress, lipid peroxidation and disease onset-mechanisms critically implicated in neurodegeneration. We also explore the potential interactions of lipofuscin with Aβ and their spatial location, and summarize evidence showing that lipofuscin may influence disease progression via feedback loops affecting cellular clearance and inflammation. Finally, we propose future research directions toward better understanding of the mechanisms of lipofuscin accumulation and improved lysosomal waste clearance in aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s40035-025-00529-x
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Dougnon, G., & Matsui, H. (2025). Lipofuscin accumulation in aging and neurodegeneration: a potential “timebomb” overlooked in Alzheimer’s disease. <em>Translational Neurodegeneration</em>. https://doi.org/10.1186/s40035-025-00529-x
Vancouver
Dougnon G, Matsui H. Lipofuscin accumulation in aging and neurodegeneration: a potential “timebomb” overlooked in Alzheimer’s disease. Translational Neurodegeneration. 2025. doi:10.1186/s40035-025-00529-x.
BibTeX
@article{godfried2025Lipofu,
title = {Lipofuscin accumulation in aging and neurodegeneration: a potential “timebomb” overlooked in Alzheimer’s disease},
author = {Godfried Dougnon and Hideaki Matsui},
journal = {Translational Neurodegeneration},
year = {2025},
doi = {10.1186/s40035-025-00529-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Digital Commons - University of South Florida (University of South Florida) 2017
Preprint · OA
Mass-spectrometry Based Proteomics of Age-related Changes in Murine Microglia
Translational Neurodegeneration 2025
Open access · CC-BY
Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications
Translational neurodegeneration 2025
Open access · OA
Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications.
Translational Neurodegeneration 2024
Open access · CC-BY
Cellular senescence as a key contributor to secondary neurodegeneration in traumatic brain injury and stroke
International Journal of Molecular Sciences 2018
Open access · CC-BY
Ageing, Cellular Senescence and Neurodegenerative Disease
Molecular Neurodegeneration 2018
Open access · CC-BY